14 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
ASTRA-OCT Spine System
FDA 510(k)
FDA Class 2
·Orthopedic
EP BLUE™
FDA UDI
INNOVATIVE HEALTHCARE CORPORATION·10813172021714·Gloves, Exam, Latex, Chemo, Non-Sterile, Powder...
BOSS Instruments
FDA UDI
BOSS INSTRUMENTS, LTD., INC.·00888515025653·Caspar Retr, 67x17mm, 8"
RADSCAN EQUIPMENT SLICKER
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
MEDICAM EVOLUX, EVOSTAR, EVOLIGHT AND EVOLASE PULSED LIGHT SYSTEM
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
ECHELON LINEAR CUTTER
FDA Adverse Event
Malfunction
·ETHICON ENDO-SURGERY, LLC.·Product code GDW·October 17, 2014
M2A MAGNUM MODULAR HD COCR 44MM
FDA Adverse Event
Injury
·BIOMET UK LTD.·Product code KWA·June 21, 2013
VIBRANT SOUNDBRIDGE
FDA Adverse Event
Malfunction
·VIBRANT MED-EL HEARING TECHNOLOGY GMBH·Product code MPV·July 8, 2011
Quanta System Sterile Optical Laser Fiber, reusable
FDA Enforcement
Class II
·Terminated·Quanta System, S.p.A.·June 16, 2021
CR PROLONG 40MM BRNG +3 RET
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code PHX·June 23, 2023
CR 40MM GLENOSPHERE +3MM COCR
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code PHX·June 23, 2023
MINI TRAY +5MM COCR +6 OFFSET
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code PHX·June 23, 2023
Reamer / Irrigator / Aspirator (RIA): RIA Drive Shafts, RIA Tube Assemblies, sterile, RIA Reamer Head, sterile (12.0mm-19.0mm); intended to clear the medullary canal of bone marrow and debris and to effectively size the medullary canal for the acceptance of an intramedullary implant or prosthesis
FDA Enforcement
Class II
·Terminated·Synthes, Inc.·July 22, 2015
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014